Skip to main content
Clinical Trials/NCT06454123
NCT06454123
Not Yet Recruiting
N/A

A Feasibility Study of a Digital Therapeutic for Adults With Recurrent Binge Eating and Obesity

Oui Therapeutics, Inc.0 sites30 target enrollmentSeptember 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Binge Eating
Sponsor
Oui Therapeutics, Inc.
Enrollment
30
Primary Endpoint
System Usability Sale (SUS)
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

The primary objective of this study is to test the feasibility of a digital therapeutic to address comorbid binge eating and obesity in adults.

Detailed Description

This single-arm, open-label clinical trial will test the feasibility, usability, acceptability, and preliminary efficacy of a digital therapeutic in reducing binge eating and weight in 30 adults with comorbid recurrent binge eating and obesity.

Registry
clinicaltrials.gov
Start Date
September 2024
End Date
June 2025
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • English speaking male or female patients, 18-70 years
  • Patients with recurrent binge eating (≥12 episodes in 3 months) and obesity (BMI ≥30)
  • Understand written and spoken English
  • Own an iPhone with iOS 11 or higher, or Android with OS 8.1 or higher
  • Willing and able to complete enrollment procedures
  • Able to understand the nature of the study and provide written informed consent

Exclusion Criteria

  • Patients with active psychosis
  • Patients who are acutely intoxicated at the time of enrollment
  • Currently enrolled in other treatment studies for the symptoms and behaviors targeted
  • Patients who are cognitively impaired
  • Patients who, in the judgment of the investigator, would have an unfavorable risk/benefit profile with respect to the digital therapeutic

Outcomes

Primary Outcomes

System Usability Sale (SUS)

Time Frame: Week 12

The SUS and a semi-structured user feedback interview will be utilized to systematically capture usability and acceptability.

Similar Trials